Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Current Pharmaceutical Biotechnology|January 31, 2012
Treating impaired cognition in schizophreniaH M Ibrahim, C A TammingaCNS Spectrums|August 18, 2004
Treating schizophrenia now and developing strategies for the next decadeC A TammingaCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1997
The promise of new drugs for schizophrenia treatmentC A TammingaJournal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2002
Partial dopamine agonists in the treatment of psychosisC A TammingaCritical Reviews in Neurobiology|January 28, 1998
Schizophrenia and glutamatergic transmissionC A TammingaDialogues in Clinical Neuroscience|October 29, 2011
Treatment mechanisms: traditional and new antipsychotic drugsC A TammingaEndocrinology and Metabolism Clinics of North America|March 1, 1988
The endocrinology of extrapyramidal system disordersB Kirkpatrick, C A TammingaNeurologic Clinics|February 1, 1988
The endocrinology of extrapyramidal system disordersB Kirkpatrick, C A TammingaExperimental Neurology|May 1, 1994
Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in ratO Shirakawa, C A TammingaPageof 21